A Phase II Randomized, Blinded, Placebo-Controlled Clinical Trial to Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell) in Adults Aged 60 Years and Above

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 0f47336daf5ee0370a78e4189eb88110e46800f8
First added on: Apr 24, 2026